Henry Schein (NASDAQ:HSIC) is a global distributor of healthcare products and services primarily to dental practices, medical offices, and other healthcare facilities. 1. Core Business Falling ...

Valued at a market cap of $8.5 billion, Henry Schein, Inc. (HSIC) is a premier global provider of healthcare solutions, ...

Analysts at Zacks Research dropped their Q2 2025 earnings per share estimates for shares of Henry Schein in a research note ...

Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for Henry Schein in a research note issued to investors on Tuesday, March 18th. Zacks Research analyst R. Department now ...

Shares of Henry Schein Inc. HSIC slid 1.12% to $68.62 Friday, on what proved to be an all-around dismal trading session for ...

Shield Healthcare does seem to be a clear outlier, with an EV to sales multiple of 1.9. But the others seem to range between 4.2 and 6.3. To put this in perspective, Henry Schein it's trading at ...

Henry Schein is part of the Zacks Medical - Dental ... representing a year-over-year change of +2.3%. EPS of $1.82 for the same period compares with $1.83 a year ago. West Pharmaceutical is ...

Henry Schein posted a quarterly adjusted profit of $1.19 per share, missing estimates of $1.21 per share.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq ... We continued to make progress on our 2022 to 2024 BOLD+1 Strategic Plan which we recently completed, exceeding our 2024 target ...

On Feb. 25, Henry Schein reported its fourth-quarter results ... Non-GAAP EPS came in at $1.19, aligning with estimates, while operating margin improved, supported by restructuring efforts.

Shares of Henry Schein Inc. HSIC slipped 1.61% to $70.84 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.08% to 5,675.29 ...